Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Heska Corp    HSKA

HESKA CORP

(HSKA)
  Report  
Delayed Quote. Delayed Nasdaq - 04/18 04:00:00 pm
74.44 USD   +1.42%
2018HESKA : 3Q Earnings Snapshot
AQ
2018HESKA : 2Q Earnings Snapshot
AQ
2018HESKA : 1Q Earnings Snapshot
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/12/2019 04/15/2019 04/16/2019 04/17/2019 04/18/2019 Date
75.88(c) 75.87(c) 74.66(c) 73.4(c) 74.44(c) Last
37 097 65 843 64 892 91 084 78 006 Volume
-2.22% -0.01% -1.59% -1.69% +1.42% Change
More quotes
Financials (USD)
Sales 2019 123 M
EBIT 2019 0,18 M
Net income 2019 0,03 M
Finance 2019 13,0 M
Yield 2019 -
Sales 2020 148 M
EBIT 2020 7,21 M
Net income 2020 5,22 M
Finance 2020 34,0 M
Yield 2020 -
P/E ratio 2019 14 888,00
P/E ratio 2020 118,16
EV / Sales2019 4,59x
EV / Sales2020 3,67x
Capitalization 576 M
More Financials
Company
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and... 
More about the company
Surperformance© ratings of Heska Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on HESKA CORP
03/21HESKA CORP : Change in Directors or Principal Officers (form 8-K)
AQ
03/08HESKA CORP : Change in Directors or Principal Officers, Financial Statements and..
AQ
03/07HESKA : Management's Discussion and Analysis of Financial Condition and Results ..
AQ
02/26HESKA CORP : Results of Operations and Financial Condition (form 8-K)
AQ
02/11HESKA : HSKA) COO Sells $750,000.00 in Stock
AQ
2018HESKA CORP : Entry into a Material Definitive Agreement, Financial Statements an..
AQ
2018HESKA : Management's Discussion and Analysis of Financial Condition and Results ..
AQ
2018HESKA : 3Q Earnings Snapshot
AQ
2018HESKA CORP : Regulation FD Disclosure (form 8-K)
AQ
2018HESKA CORP : Other Events (form 8-K)
AQ
More news
Analyst Recommendations on HESKA CORP
More recommendations
Sector news : Veterinary Medical Equipment & Supplies
04/18ESSILORLUXOTTICA : shareholder body propose independent director to ease deadloc..
RE
04/18GLOBAL MARKETS LIVE : Commerzbank, Amazon, Pinterest, Lyft…
04/18ESSILORLUXOTTICA : Starts Search for New CEO
DJ
04/17ESSILORLUXOTTICA : hires two headhunters to find new CEO
RE
04/17Becton Dickinson Down Over 7%, on Pace for Largest Percent Decrease Since Jul..
DJ
More sector news : Veterinary Medical Equipment & Supplies
Chart HESKA CORP
Duration : Period :
Heska Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HESKA CORP
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 96,7 $
Spread / Average Target 30%
EPS Revisions
Managers
NameTitle
Kevin S. Wilson President, Chief Executive Officer & Director
Scott Humphrey Chairman
Jason A. Napolitano COO, Secretary & Chief Strategist
G. Irwin Gordon Independent Director
Sharon J. Larson Director
Sector and Competitors
1st jan.Capitalization (M$)
HESKA CORP-13.54%576
ABBOTT LABORATORIES2.20%129 838
MEDTRONIC PLC-7.41%112 952
STRYKER CORPORATION15.00%67 256
BECTON, DICKINSON AND COMPANY1.14%61 317
ESSILORLUXOTTICA-2.08%53 011